About
Banook at a glance
Over the past 25 years, the company has evolved significantly, but its core values remain unchanged. What began as a small family business continues to grow with determination.
About
Banook at a glance
Over the past 25 years, the company has evolved significantly, but its core values remain unchanged. What began as a small family business continues to grow with determination.
0+
0+
years of experience
0+
0+
years of experience
0+
0+
years of experience
0+
0+
employees
0+
0+
employees
0+
0+
employees
0
0
offices all over the world
0
0
offices all over the world
0
0
offices all over the world
0
0
participation in Clinical Trials
0
0
participation in Clinical Trials
0
0
participation in Clinical Trials
Solutions
Cardiac Safety
We ensure optimal cardiovascular monitoring in Clinical Trials thanks to our provisioning, project, data management and medical experts' capabilities.
Learn more
Central Imaging
From early to late phase, we deliver exceptional expertise across a range of therapeutic areas and indications, delivering customized services to align with your unique needs at every stage of development process.
Learn more
eCOA / ePRO
Discover our personalized site and patient solutions, designed specifically to equip you with the devices you need for a successful study experience.
Learn more
Endpoint Adjudication
Entrust your project to our dedicated scientific board. We undertake comprehensive reviews and expert management to ensure timely delivery and adherence to regulatory standards.
Learn more
Solutions
Cardiac Safety
We ensure optimal cardiovascular monitoring in Clinical Trials thanks to our provisioning, project, data management and medical experts' capabilities.
Learn more
Central Imaging
From early to late phase, we deliver exceptional expertise across a range of therapeutic areas and indications, delivering customized services to align with your unique needs at every stage of development process.
Learn more
eCOA / ePRO
Discover our personalized site and patient solutions, designed specifically to equip you with the devices you need for a successful study experience.
Learn more
Endpoint Adjudication
Entrust your project to our dedicated scientific board. We undertake comprehensive reviews and expert management to ensure timely delivery and adherence to regulatory standards.
Learn more
Solutions
Cardiac Safety
We ensure optimal cardiovascular monitoring in Clinical Trials thanks to our provisioning, project, data management and medical experts' capabilities.
Learn more
Central Imaging
From early to late phase, we deliver exceptional expertise across a range of therapeutic areas and indications, delivering customized services to align with your unique needs at every stage of development process.
Learn more
eCOA / ePRO
Discover our personalized site and patient solutions, designed specifically to equip you with the devices you need for a successful study experience.
Learn more
Endpoint Adjudication
Entrust your project to our dedicated scientific board. We undertake comprehensive reviews and expert management to ensure timely delivery and adherence to regulatory standards.
Learn more
Our manifesto
Our manifesto
Our manifesto
In the world of clinical research, time is precious.
Every day counts.
Every piece of data is crucial.
And all the while, science waits.
Patients are waiting.
We fundamentally believe that science can transform,
faster, human health.
Not tomorrow. Today.
When industry standardizes, patients become mere data.
When processes become rigid, innovation falters.
When delays drag on, hope fades.
This is not how science should move forward.
That's not how we want to work. That's why we've chosen a different path.
The one where 500 scientific experts work tirelessly.
The one where an ECG is analyzed in 30 minutes, not days.
The one where a study starts in less than a month, not in quarters.
Where 99% of commitments are kept on time.
Where every promise becomes a concrete result.
We are the guardians of this vision.
The artisans of a more agile science.
Architects of a future where research moves at the pace of innovation.
We are BANOOK.
And where others promise, we deliver.
Values
Values
Values
Growing together through people, passion, and expertise
People are at the heart of everything we do. Their passion, expertise, and dedication are what drive our success.
We believe in creating a workplace where knowledge is shared, skills are continuously developed, and every team member feels valued.
This human-centered approach fosters loyalty, long-term collaboration, and a deep well of expertise that benefits our partners every day.
Behind each project, there is a team committed not just to excellence—but to making a real difference in clinical research.
Time (really) flies
Time (really) flies
Time (really) flies
2025
New name and brand identity: welcome to Banook
2022
Opening of a Boston office
2020
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
Keosys continues its growth by signing a multi-year multi study contract with a top 5 pharmaceutical company.2019
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
2018
First project in China,
Keosys launches its centralized dosimetry services including site calibration activities.
2017
Opening of offices in Canada
2016
Partnering in healthcare service with care givers and nursing homes
2015
Founding of BANOOK GROUP
2013
Launch of ATRIUM suite
Keosys launch U.S. and Asia offices and joins a large international trial in the Asian market.
2012
1st contract in Africa and partnership with NPOs
2011
Launch of BANOOK Central Imaging and BANOOK Medical Services
Launch of a proprietary Remote Reading Solutions (patented), allowing physicians to view and analyze multi-modality medical images with diagnostic grade quality.
2010
Lunch of Device Rental Activities. Set-up of service for logistics & helpdesk. First step in geographical expansion. Partnership with Institut Gustave Roussy (France, Villejuif).
2009
Keosys works with academics, medical experts and pharmaceutical companies to design and implement a state-of-the-art, web-based imaging platform to be used in clinical trials. The IMAGYS platform is born.
2007
Keosys acts as imaging provider for H10, the first multicenter European study involving image-based treatment arm selection, in partnership with EORTC.
2006
First TQT (Thorough QT study) with big pharma. CARDIABASE becomes the leader in Europe for early phase studies in Cardiac Safety.
Extension of our product offering with the development of Advanced Nuclear Medicine Workstations (25% share of the French market within a few years).
2005
Launch of our vendor-neutral PACS system and CD burner, including fused hybrid imaging viewing capabilities.
2004
Launch of Endpoint Adjudication services
2003
Launch of Positoscope, the first electronic light box for PET/CT centralized interpretation
2002
Starting up ECG digital data processing
2001
Incorporation of Keosys Medical Imaging in Saint-Herblain
2000
First contract with Tops-Pharma
1999
Founding of CARDIABASE By Dr Pascal Voirot, M.D
2025
New name and brand identity: welcome to Banook
2022
Opening of a Boston office
2020
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
Keosys continues its growth by signing a multi-year multi study contract with a top 5 pharmaceutical company.2019
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
2018
First project in China,
Keosys launches its centralized dosimetry services including site calibration activities.
2017
Opening of offices in Canada
2016
Partnering in healthcare service with care givers and nursing homes
2015
Founding of BANOOK GROUP
2013
Launch of ATRIUM suite
Keosys launch U.S. and Asia offices and joins a large international trial in the Asian market.
2012
1st contract in Africa and partnership with NPOs
2011
Launch of BANOOK Central Imaging and BANOOK Medical Services
Launch of a proprietary Remote Reading Solutions (patented), allowing physicians to view and analyze multi-modality medical images with diagnostic grade quality.
2010
Lunch of Device Rental Activities. Set-up of service for logistics & helpdesk. First step in geographical expansion. Partnership with Institut Gustave Roussy (France, Villejuif).
2009
Keosys works with academics, medical experts and pharmaceutical companies to design and implement a state-of-the-art, web-based imaging platform to be used in clinical trials. The IMAGYS platform is born.
2007
Keosys acts as imaging provider for H10, the first multicenter European study involving image-based treatment arm selection, in partnership with EORTC.
2006
First TQT (Thorough QT study) with big pharma. CARDIABASE becomes the leader in Europe for early phase studies in Cardiac Safety.
Extension of our product offering with the development of Advanced Nuclear Medicine Workstations (25% share of the French market within a few years).
2005
Launch of our vendor-neutral PACS system and CD burner, including fused hybrid imaging viewing capabilities.
2004
Launch of Endpoint Adjudication services
2003
Launch of Positoscope, the first electronic light box for PET/CT centralized interpretation
2002
Starting up ECG digital data processing
2001
Incorporation of Keosys Medical Imaging in Saint-Herblain
2000
First contract with Tops-Pharma
1999
Founding of CARDIABASE By Dr Pascal Voirot, M.D
2025
New name and brand identity: welcome to Banook
2022
Opening of a Boston office
2020
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
Keosys continues its growth by signing a multi-year multi study contract with a top 5 pharmaceutical company.2019
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
2018
First project in China,
Keosys launches its centralized dosimetry services including site calibration activities.
2017
Opening of offices in Canada
2016
Partnering in healthcare service with care givers and nursing homes
2015
Founding of BANOOK GROUP
2013
Launch of ATRIUM suite
Keosys launch U.S. and Asia offices and joins a large international trial in the Asian market.
2012
1st contract in Africa and partnership with NPOs
2011
Launch of BANOOK Central Imaging and BANOOK Medical Services
Launch of a proprietary Remote Reading Solutions (patented), allowing physicians to view and analyze multi-modality medical images with diagnostic grade quality.
2010
Lunch of Device Rental Activities. Set-up of service for logistics & helpdesk. First step in geographical expansion. Partnership with Institut Gustave Roussy (France, Villejuif).
2009
Keosys works with academics, medical experts and pharmaceutical companies to design and implement a state-of-the-art, web-based imaging platform to be used in clinical trials. The IMAGYS platform is born.
2007
Keosys acts as imaging provider for H10, the first multicenter European study involving image-based treatment arm selection, in partnership with EORTC.
2006
First TQT (Thorough QT study) with big pharma. CARDIABASE becomes the leader in Europe for early phase studies in Cardiac Safety.
Extension of our product offering with the development of Advanced Nuclear Medicine Workstations (25% share of the French market within a few years).
2005
Launch of our vendor-neutral PACS system and CD burner, including fused hybrid imaging viewing capabilities.
2004
Launch of Endpoint Adjudication services
2003
Launch of Positoscope, the first electronic light box for PET/CT centralized interpretation
2002
Starting up ECG digital data processing
2001
Incorporation of Keosys Medical Imaging in Saint-Herblain
2000
First contract with Tops-Pharma
1999
Founding of CARDIABASE By Dr Pascal Voirot, M.D
2025
New name and brand identity: welcome to Banook
2022
Opening of a Boston office
2020
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
Keosys continues its growth by signing a multi-year multi study contract with a top 5 pharmaceutical company.2019
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
2018
First project in China,
Keosys launches its centralized dosimetry services including site calibration activities.
2017
Opening of offices in Canada
2016
Partnering in healthcare service with care givers and nursing homes
2015
Founding of BANOOK GROUP
2013
Launch of ATRIUM suite
Keosys launch U.S. and Asia offices and joins a large international trial in the Asian market.
2012
1st contract in Africa and partnership with NPOs
2011
Launch of BANOOK Central Imaging and BANOOK Medical Services
Launch of a proprietary Remote Reading Solutions (patented), allowing physicians to view and analyze multi-modality medical images with diagnostic grade quality.
2010
Lunch of Device Rental Activities. Set-up of service for logistics & helpdesk. First step in geographical expansion. Partnership with Institut Gustave Roussy (France, Villejuif).
2009
Keosys works with academics, medical experts and pharmaceutical companies to design and implement a state-of-the-art, web-based imaging platform to be used in clinical trials. The IMAGYS platform is born.
2007
Keosys acts as imaging provider for H10, the first multicenter European study involving image-based treatment arm selection, in partnership with EORTC.
2006
First TQT (Thorough QT study) with big pharma. CARDIABASE becomes the leader in Europe for early phase studies in Cardiac Safety.
Extension of our product offering with the development of Advanced Nuclear Medicine Workstations (25% share of the French market within a few years).
2005
Launch of our vendor-neutral PACS system and CD burner, including fused hybrid imaging viewing capabilities.
2004
Launch of Endpoint Adjudication services
2003
Launch of Positoscope, the first electronic light box for PET/CT centralized interpretation
2002
Starting up ECG digital data processing
2001
Incorporation of Keosys Medical Imaging in Saint-Herblain
2000
First contract with Tops-Pharma
1999
Founding of CARDIABASE By Dr Pascal Voirot, M.D
2025
New name and brand identity: welcome to Banook
2022
Opening of a Boston office
2020
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
Keosys continues its growth by signing a multi-year multi study contract with a top 5 pharmaceutical company.2019
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
2018
First project in China,
Keosys launches its centralized dosimetry services including site calibration activities.
2017
Opening of offices in Canada
2016
Partnering in healthcare service with care givers and nursing homes
2015
Founding of BANOOK GROUP
2013
Launch of ATRIUM suite
Keosys launch U.S. and Asia offices and joins a large international trial in the Asian market.
2012
1st contract in Africa and partnership with NPOs
2011
Launch of BANOOK Central Imaging and BANOOK Medical Services
Launch of a proprietary Remote Reading Solutions (patented), allowing physicians to view and analyze multi-modality medical images with diagnostic grade quality.
2010
Lunch of Device Rental Activities. Set-up of service for logistics & helpdesk. First step in geographical expansion. Partnership with Institut Gustave Roussy (France, Villejuif).
2009
Keosys works with academics, medical experts and pharmaceutical companies to design and implement a state-of-the-art, web-based imaging platform to be used in clinical trials. The IMAGYS platform is born.
2007
Keosys acts as imaging provider for H10, the first multicenter European study involving image-based treatment arm selection, in partnership with EORTC.
2006
First TQT (Thorough QT study) with big pharma. CARDIABASE becomes the leader in Europe for early phase studies in Cardiac Safety.
Extension of our product offering with the development of Advanced Nuclear Medicine Workstations (25% share of the French market within a few years).
2005
Launch of our vendor-neutral PACS system and CD burner, including fused hybrid imaging viewing capabilities.
2004
Launch of Endpoint Adjudication services
2003
Launch of Positoscope, the first electronic light box for PET/CT centralized interpretation
2002
Starting up ECG digital data processing
2001
Incorporation of Keosys Medical Imaging in Saint-Herblain
2000
First contract with Tops-Pharma
1999
Founding of CARDIABASE By Dr Pascal Voirot, M.D
2025
New name and brand identity: welcome to Banook
2022
Opening of a Boston office
2020
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
Keosys continues its growth by signing a multi-year multi study contract with a top 5 pharmaceutical company.2019
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
2018
First project in China,
Keosys launches its centralized dosimetry services including site calibration activities.
2017
Opening of offices in Canada
2016
Partnering in healthcare service with care givers and nursing homes
2015
Founding of BANOOK GROUP
2013
Launch of ATRIUM suite
Keosys launch U.S. and Asia offices and joins a large international trial in the Asian market.
2012
1st contract in Africa and partnership with NPOs
2011
Launch of BANOOK Central Imaging and BANOOK Medical Services
Launch of a proprietary Remote Reading Solutions (patented), allowing physicians to view and analyze multi-modality medical images with diagnostic grade quality.
2010
Lunch of Device Rental Activities. Set-up of service for logistics & helpdesk. First step in geographical expansion. Partnership with Institut Gustave Roussy (France, Villejuif).
2009
Keosys works with academics, medical experts and pharmaceutical companies to design and implement a state-of-the-art, web-based imaging platform to be used in clinical trials. The IMAGYS platform is born.
2007
Keosys acts as imaging provider for H10, the first multicenter European study involving image-based treatment arm selection, in partnership with EORTC.
2006
First TQT (Thorough QT study) with big pharma. CARDIABASE becomes the leader in Europe for early phase studies in Cardiac Safety.
Extension of our product offering with the development of Advanced Nuclear Medicine Workstations (25% share of the French market within a few years).
2005
Launch of our vendor-neutral PACS system and CD burner, including fused hybrid imaging viewing capabilities.
2004
Launch of Endpoint Adjudication services
2003
Launch of Positoscope, the first electronic light box for PET/CT centralized interpretation
2002
Starting up ECG digital data processing
2001
Incorporation of Keosys Medical Imaging in Saint-Herblain
2000
First contract with Tops-Pharma
1999
Founding of CARDIABASE By Dr Pascal Voirot, M.D
2025
New name and brand identity: welcome to Banook
2022
Opening of a Boston office
2020
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
Keosys continues its growth by signing a multi-year multi study contract with a top 5 pharmaceutical company.2019
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
2018
First project in China,
Keosys launches its centralized dosimetry services including site calibration activities.
2017
Opening of offices in Canada
2016
Partnering in healthcare service with care givers and nursing homes
2015
Founding of BANOOK GROUP
2013
Launch of ATRIUM suite
Keosys launch U.S. and Asia offices and joins a large international trial in the Asian market.
2012
1st contract in Africa and partnership with NPOs
2011
Launch of BANOOK Central Imaging and BANOOK Medical Services
Launch of a proprietary Remote Reading Solutions (patented), allowing physicians to view and analyze multi-modality medical images with diagnostic grade quality.
2010
Lunch of Device Rental Activities. Set-up of service for logistics & helpdesk. First step in geographical expansion. Partnership with Institut Gustave Roussy (France, Villejuif).
2009
Keosys works with academics, medical experts and pharmaceutical companies to design and implement a state-of-the-art, web-based imaging platform to be used in clinical trials. The IMAGYS platform is born.
2007
Keosys acts as imaging provider for H10, the first multicenter European study involving image-based treatment arm selection, in partnership with EORTC.
2006
First TQT (Thorough QT study) with big pharma. CARDIABASE becomes the leader in Europe for early phase studies in Cardiac Safety.
Extension of our product offering with the development of Advanced Nuclear Medicine Workstations (25% share of the French market within a few years).
2005
Launch of our vendor-neutral PACS system and CD burner, including fused hybrid imaging viewing capabilities.
2004
Launch of Endpoint Adjudication services
2003
Launch of Positoscope, the first electronic light box for PET/CT centralized interpretation
2002
Starting up ECG digital data processing
2001
Incorporation of Keosys Medical Imaging in Saint-Herblain
2000
First contract with Tops-Pharma
1999
Founding of CARDIABASE By Dr Pascal Voirot, M.D
2025
New name and brand identity: welcome to Banook
2022
Opening of a Boston office
2020
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
Keosys continues its growth by signing a multi-year multi study contract with a top 5 pharmaceutical company.2019
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
2018
First project in China,
Keosys launches its centralized dosimetry services including site calibration activities.
2017
Opening of offices in Canada
2016
Partnering in healthcare service with care givers and nursing homes
2015
Founding of BANOOK GROUP
2013
Launch of ATRIUM suite
Keosys launch U.S. and Asia offices and joins a large international trial in the Asian market.
2012
1st contract in Africa and partnership with NPOs
2011
Launch of BANOOK Central Imaging and BANOOK Medical Services
Launch of a proprietary Remote Reading Solutions (patented), allowing physicians to view and analyze multi-modality medical images with diagnostic grade quality.
2010
Lunch of Device Rental Activities. Set-up of service for logistics & helpdesk. First step in geographical expansion. Partnership with Institut Gustave Roussy (France, Villejuif).
2009
Keosys works with academics, medical experts and pharmaceutical companies to design and implement a state-of-the-art, web-based imaging platform to be used in clinical trials. The IMAGYS platform is born.
2007
Keosys acts as imaging provider for H10, the first multicenter European study involving image-based treatment arm selection, in partnership with EORTC.
2006
First TQT (Thorough QT study) with big pharma. CARDIABASE becomes the leader in Europe for early phase studies in Cardiac Safety.
Extension of our product offering with the development of Advanced Nuclear Medicine Workstations (25% share of the French market within a few years).
2005
Launch of our vendor-neutral PACS system and CD burner, including fused hybrid imaging viewing capabilities.
2004
Launch of Endpoint Adjudication services
2003
Launch of Positoscope, the first electronic light box for PET/CT centralized interpretation
2002
Starting up ECG digital data processing
2001
Incorporation of Keosys Medical Imaging in Saint-Herblain
2000
First contract with Tops-Pharma
1999
Founding of CARDIABASE By Dr Pascal Voirot, M.D
2025
New name and brand identity: welcome to Banook
2022
Opening of a Boston office
2020
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
Keosys continues its growth by signing a multi-year multi study contract with a top 5 pharmaceutical company.2019
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
2018
First project in China,
Keosys launches its centralized dosimetry services including site calibration activities.
2017
Opening of offices in Canada
2016
Partnering in healthcare service with care givers and nursing homes
2015
Founding of BANOOK GROUP
2013
Launch of ATRIUM suite
Keosys launch U.S. and Asia offices and joins a large international trial in the Asian market.
2012
1st contract in Africa and partnership with NPOs
2011
Launch of BANOOK Central Imaging and BANOOK Medical Services
Launch of a proprietary Remote Reading Solutions (patented), allowing physicians to view and analyze multi-modality medical images with diagnostic grade quality.
2010
Lunch of Device Rental Activities. Set-up of service for logistics & helpdesk. First step in geographical expansion. Partnership with Institut Gustave Roussy (France, Villejuif).
2009
Keosys works with academics, medical experts and pharmaceutical companies to design and implement a state-of-the-art, web-based imaging platform to be used in clinical trials. The IMAGYS platform is born.
2007
Keosys acts as imaging provider for H10, the first multicenter European study involving image-based treatment arm selection, in partnership with EORTC.
2006
First TQT (Thorough QT study) with big pharma. CARDIABASE becomes the leader in Europe for early phase studies in Cardiac Safety.
Extension of our product offering with the development of Advanced Nuclear Medicine Workstations (25% share of the French market within a few years).
2005
Launch of our vendor-neutral PACS system and CD burner, including fused hybrid imaging viewing capabilities.
2004
Launch of Endpoint Adjudication services
2003
Launch of Positoscope, the first electronic light box for PET/CT centralized interpretation
2002
Starting up ECG digital data processing
2001
Incorporation of Keosys Medical Imaging in Saint-Herblain
2000
First contract with Tops-Pharma
1999
Founding of CARDIABASE By Dr Pascal Voirot, M.D
2025
New name and brand identity: welcome to Banook
2022
Opening of a Boston office
2020
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
Keosys continues its growth by signing a multi-year multi study contract with a top 5 pharmaceutical company.2019
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
2018
First project in China,
Keosys launches its centralized dosimetry services including site calibration activities.
2017
Opening of offices in Canada
2016
Partnering in healthcare service with care givers and nursing homes
2015
Founding of BANOOK GROUP
2013
Launch of ATRIUM suite
Keosys launch U.S. and Asia offices and joins a large international trial in the Asian market.
2012
1st contract in Africa and partnership with NPOs
2011
Launch of BANOOK Central Imaging and BANOOK Medical Services
Launch of a proprietary Remote Reading Solutions (patented), allowing physicians to view and analyze multi-modality medical images with diagnostic grade quality.
2010
Lunch of Device Rental Activities. Set-up of service for logistics & helpdesk. First step in geographical expansion. Partnership with Institut Gustave Roussy (France, Villejuif).
2009
Keosys works with academics, medical experts and pharmaceutical companies to design and implement a state-of-the-art, web-based imaging platform to be used in clinical trials. The IMAGYS platform is born.
2007
Keosys acts as imaging provider for H10, the first multicenter European study involving image-based treatment arm selection, in partnership with EORTC.
2006
First TQT (Thorough QT study) with big pharma. CARDIABASE becomes the leader in Europe for early phase studies in Cardiac Safety.
Extension of our product offering with the development of Advanced Nuclear Medicine Workstations (25% share of the French market within a few years).
2005
Launch of our vendor-neutral PACS system and CD burner, including fused hybrid imaging viewing capabilities.
2004
Launch of Endpoint Adjudication services
2003
Launch of Positoscope, the first electronic light box for PET/CT centralized interpretation
2002
Starting up ECG digital data processing
2001
Incorporation of Keosys Medical Imaging in Saint-Herblain
2000
First contract with Tops-Pharma
1999
Founding of CARDIABASE By Dr Pascal Voirot, M.D
2025
New name and brand identity: welcome to Banook
2022
Opening of a Boston office
2020
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
Keosys continues its growth by signing a multi-year multi study contract with a top 5 pharmaceutical company.2019
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
2018
First project in China,
Keosys launches its centralized dosimetry services including site calibration activities.
2017
Opening of offices in Canada
2016
Partnering in healthcare service with care givers and nursing homes
2015
Founding of BANOOK GROUP
2013
Launch of ATRIUM suite
Keosys launch U.S. and Asia offices and joins a large international trial in the Asian market.
2012
1st contract in Africa and partnership with NPOs
2011
Launch of BANOOK Central Imaging and BANOOK Medical Services
Launch of a proprietary Remote Reading Solutions (patented), allowing physicians to view and analyze multi-modality medical images with diagnostic grade quality.
2010
Lunch of Device Rental Activities. Set-up of service for logistics & helpdesk. First step in geographical expansion. Partnership with Institut Gustave Roussy (France, Villejuif).
2009
Keosys works with academics, medical experts and pharmaceutical companies to design and implement a state-of-the-art, web-based imaging platform to be used in clinical trials. The IMAGYS platform is born.
2007
Keosys acts as imaging provider for H10, the first multicenter European study involving image-based treatment arm selection, in partnership with EORTC.
2006
First TQT (Thorough QT study) with big pharma. CARDIABASE becomes the leader in Europe for early phase studies in Cardiac Safety.
Extension of our product offering with the development of Advanced Nuclear Medicine Workstations (25% share of the French market within a few years).
2005
Launch of our vendor-neutral PACS system and CD burner, including fused hybrid imaging viewing capabilities.
2004
Launch of Endpoint Adjudication services
2003
Launch of Positoscope, the first electronic light box for PET/CT centralized interpretation
2002
Starting up ECG digital data processing
2001
Incorporation of Keosys Medical Imaging in Saint-Herblain
2000
First contract with Tops-Pharma
1999
Founding of CARDIABASE By Dr Pascal Voirot, M.D
2025
New name and brand identity: welcome to Banook
2022
Opening of a Boston office
2020
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
Keosys continues its growth by signing a multi-year multi study contract with a top 5 pharmaceutical company.2019
Turenne Groupe joins the company’s capital – We are actively involved in research against covid-19
2018
First project in China,
Keosys launches its centralized dosimetry services including site calibration activities.
2017
Opening of offices in Canada
2016
Partnering in healthcare service with care givers and nursing homes
2015
Founding of BANOOK GROUP
2013
Launch of ATRIUM suite
Keosys launch U.S. and Asia offices and joins a large international trial in the Asian market.
2012
1st contract in Africa and partnership with NPOs
2011
Launch of BANOOK Central Imaging and BANOOK Medical Services
Launch of a proprietary Remote Reading Solutions (patented), allowing physicians to view and analyze multi-modality medical images with diagnostic grade quality.
2010
Lunch of Device Rental Activities. Set-up of service for logistics & helpdesk. First step in geographical expansion. Partnership with Institut Gustave Roussy (France, Villejuif).
2009
Keosys works with academics, medical experts and pharmaceutical companies to design and implement a state-of-the-art, web-based imaging platform to be used in clinical trials. The IMAGYS platform is born.
2007
Keosys acts as imaging provider for H10, the first multicenter European study involving image-based treatment arm selection, in partnership with EORTC.
2006
First TQT (Thorough QT study) with big pharma. CARDIABASE becomes the leader in Europe for early phase studies in Cardiac Safety.
Extension of our product offering with the development of Advanced Nuclear Medicine Workstations (25% share of the French market within a few years).
2005
Launch of our vendor-neutral PACS system and CD burner, including fused hybrid imaging viewing capabilities.
2004
Launch of Endpoint Adjudication services
2003
Launch of Positoscope, the first electronic light box for PET/CT centralized interpretation
2002
Starting up ECG digital data processing
2001
Incorporation of Keosys Medical Imaging in Saint-Herblain
2000
First contract with Tops-Pharma
1999
Founding of CARDIABASE By Dr Pascal Voirot, M.D
